Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Johan Enquist in Pharmaceutical Modulation
Introduction
Johan Enquist, located in San Francisco, CA, is a prominent inventor known for his significant contributions to pharmaceutical sciences. With a focus on modulation of G-protein coupled receptors, Enquist's work has the potential to reshape therapeutic approaches for various diseases and disorders.
Latest Patents
Enquist holds a patent for "Modulators of G-protein coupled receptors." This patent describes chemical entities, including compounds or their pharmaceutically acceptable salts, hydrates, or prodrugs, that can modulate the activities of the glucagon-like peptide-1 receptor (GLP-1R) and the gastric inhibitory polypeptide receptor (GIPR). These innovative compounds are particularly valuable in treating conditions where modulating GLP-1R and GIPR activities can benefit underlying pathologies or their symptoms. The patent also details how these entities can enhance existing GLP-1R and GIPR signaling, thereby providing avenues for therapeutic advancements.
Career Highlights
Enquist has made notable strides during his tenure at Cannot Therapeutics, Inc. His innovative research focuses on the therapeutic applications of receptor modulation, lending support to the development of treatments for metabolic disorders. His patent represents a significant achievement in translating scientific concepts into potential clinical applications.
Collaborations
At Cannot Therapeutics, Johan Enquist collaborates with esteemed colleagues Shyam Krishnan and Suman Atwal. Together, their collective expertise enhances the potential for breakthrough innovations in the realm of pharmacological modulation, further driving advancements in medical science.
Conclusion
Johan Enquist stands out as an inventor whose work has the potential to influence the future of medication and treatment strategies. Through his patent on modulators of G-protein coupled receptors, Enquist showcases the important intersection of innovation and practical application in pharmaceutical research. His ongoing collaborations and dedication to scientific advancements contribute to a brighter future in healthcare solutions.